340

Compound name
Volasertib
Alt Name
BI6727
BI 6727
BI-6727
Compound Image
volasertib.jpg
SMILES
CCC1C(=O)N(C2=CN=C(N=C2N1C(C)C)NC3=C(C=C(C=C3)C(=O)NC4CCC(CC4)N5CCN(CC5)CC6CC6)OC)C
MW
618.81
Brutto
C34H50N8O3
InChI
InChI=1S/C34H50N8O3/c1-6-28-33(44)39(4)29-20-35-34(38-31(29)42(28)22(2)3)37-27-14-9-24(19-30(27)45-5)32(43)36-25-10-12-26(13-11-25)41-17-15-40(16-18-41)21-23-7-8-23/h9,14,19-20,22-23,25-26,28H,6-8,10-13,15-18,21H2,1-5H3,(H,36,43)(H,35,37,38)/t25?,26?,28-/m1/s1
InChI Key
SXNJFOWDRLKDSF-XKHVUIRMSA-N
Approval Jurisdiction
2014 FDA
Approved for clinical use
Acute Myeloid Leukemia
CAS
755038-65-4
PubChem CID
10461508
Action
PLK1
Approved Drug List
1
Commercial Vendor
Selleck